First Page | Meta Content | |
---|---|---|
Document Date: 2010-04-21 04:46:55Open Document File Size: 402,18 KBShare Result on FacebookCityHelsinki / /CompanyNovartis Pharmaceuticals / ACE / /CountryPoland / Taiwan / Germany / Hungary / France / Russia / United States / Netherlands / Italy / Canada / Slovakia / Lithuania / Latvia / Sweden / Finland / Spain / Denmark / / /EventProduct Recall / Product Issues / FDA Phase / /FacilityComenius University / /IndustryTermtreatment of cardiovascular disorders / treatment of hypertension / /MedicalConditionmild-to-moderate hypertension / /OrganizationComenius University / Bratislava / /PersonLuis Miguel Ruilope / Andrej Dukat / Yves Lacourcière / Michael Böhm / Martin P Lefkowitz / /Positionmediator / Major / messenger / /Productvalsartan / consent / period / cholestyramine / LCZ696 / AHU377 / /TechnologyX-ray / /URLwww.thelancet.com / /SocialTag |